Page last updated: 2024-08-23

phenyl acetate and Familial Combined Hyperlipidemia

phenyl acetate has been researched along with Familial Combined Hyperlipidemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, AS; Davidson, MH; Davignon, J; Dujovne, CA; Heinonen, T; Insull, W; Keilson, LM; Koren, M; McLain, R; Schrott, H; Sprecher, D1

Trials

1 trial(s) available for phenyl acetate and Familial Combined Hyperlipidemia

ArticleYear
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
    Atherosclerosis, 2001, Volume: 157, Issue:1

    Topics: Acetamides; Acetates; Adult; Aged; Double-Blind Method; Female; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Treatment Outcome

2001